Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fontan Udenafil Exercise Longitudinal Assessment Trial (FUEL)

NCT02741115 is registered in ClinicalTrials.gov with Mezzion Pharma Co. Ltd as lead sponsor.

NCT NCT02741115
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02741115 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fontan Udenafil Exercise Longitudinal Assessment Trial (FUEL)
Lead sponsor
Mezzion Pharma Co. Ltd
Phase
Phase 3
Overall status
Completed
Start date
July 22, 2016
Completion date
April 30, 2019
Enrollment
400 (actual)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

single ventricle heart disease